中国首台新药研发加速器质谱落户宁波,康龙化成全球放射性同位素分析测试平台全面升级!中国宁波,2025年7月7日—康龙化成(北京)新药技术股份有限公司(股票代码:300759.SZ / 3759.HK,以下简称“康龙化成”)宣布,中国首台应用于新药研发的低能耗加速器质谱(Accelerator Mass Spectrometry,AMS)在宁波完成安装调试,助力公司进一步提升放射性同位素高灵敏度、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.